Pharmaceutical

Record number of respiratory syncytial virus (RSV) designations awarded in 2022

In 2022, global regulatory authorities awarded a record ten review designations for respiratory syncytial virus (RSV)-indicated drugs.

Sep 9, 2023 - 20:00
Record number of respiratory syncytial virus (RSV) designations awarded in 2022
In 2022, global regulatory authorities awarded a record ten review designations for respiratory syncytial virus (RSV)-indicated drugs.
Read the original article

Tags:

Previous Article

Eloxx moves ahead with plans with gene therapy for rare kidney disorder

Next Article

Otsuka and ShapeTX to develop gene therapies for eye diseases

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Evotec extends collaboration with Bristol Myers Squibb

Evotec extends collaboration with Bristol Myers Squibb

Mar 29, 2023

FibroGen axes 75% of staff after lead cancer therapy fails in Phase III trials

FibroGen axes 75% of staff after lead cancer therapy fa...

Aug 1, 2024

Opinion: Drug pricing and the ‘impossible trinity’ for patients

Opinion: Drug pricing and the ‘impossible trinity’ for ...

Jul 24, 2023